CD274 and neoplasm: Pharmacologic inhibition of adipogenesis in mammary tumors reduces PD-L1 expression and enhances anti-tumor efficacy, highlighting a potential role of the ASC population to modulate therapeutic effectiveness by controlling adipogenesis (Wu et al., 2018).